66621-0150 : Anascorp 24 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 66621-0150 |
| Labeler: | Rare Disease Therapeutics, Inc |
| Product Type: | Human Prescription Drug |
| Drug Name: | Anascorp |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | BLA125335 |
| Rev. Date: |
NDC Package Codes:
- 66621-0150-1: 1 VIAL IN 1 CARTON (66621‑0150‑1) > 10 ML IN 1 VIAL
- 66621-0150-2: 1 VIAL IN 1 CARTON (66621‑0150‑2) > 10 ML IN 1 VIAL (66621‑0150‑1)
Active Ingredients:
- Centruroides Fab2 Antivenin (Equine)
Dosage Strength:
- 3.8 mg/mL
Pharmaceutical Classes:
- Antivenin [EPC]
- Passively Acquired Immunity [PE]
- Venom Neutralization [MoA]
- Antivenins [CS]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 66619-131Next: 66621-0790 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
